Brief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
09/09/2024 22:29
* EIGER BIOPHARMACEUTICALS: ON SEPT 5, BANKRUPTCY COURT ENTERED ORDER CONFIRMING FIFTH AMENDED JOINT PLAN OF LIQUIDATION OF CO & ITS DEBTOR AFFILIATES Source text for Eikon: ID:n0001193125-24-215909 Further company coverage: [ ]
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview